Integrin CD11b is a differentiation marker of the myelomonocytic lineage and an important mediator of inflammation. Expression of the CD11b gene is transcriptionally induced as myeloid precursors differentiate into mature cells, then drops as monocytes further differentiate into macrophages. Previous studies have identified elements and factors involved in the transcriptional activation of the CD11b gene during myeloid differentiation, but no data exists regarding potential down-regulatory factors, especially in the later stages of differentiation. Using two copies of a GC-rich element (-141 to -110) in the CD11b promoter, we probed a cDNA expression library for interacting proteins. Three clones were identified among 9.1 million screened, all encoding the DNA binding domain of the zinc finger factor ZBP-89.
INTRODUCTION
CD11b is the alpha subunit of the integrin heterodimer CD11b/CD18, one of four members of the 2 integrins 1 . It is expressed on myelomonocytic cells and mediates essential adhesion-dependent functions. These include adhesion, migration, phagocytosis, degranulation, antibody-dependent cytotoxicity, and release of proteolytic enzymes during the inflammatory response 1 . Deficiency of CD11b and the other 2 integrins in the inherited disease leukocyte adhesion molecule deficiency 2 predisposes to life-threatening bacterial infections. Increased expression of CD11b on the other hand, leads to poorly coordinated adhesive functions, thus contributing to the genesis of several pathologic states such as ischemia-reperfusion injury and immune complex diseases [3] [4] [5] [6] .
CD11b is a myeloid specific marker. During hematopoiesis, it is first detected at the myelocytic and monoblastic stages 7, 8 , and its expression is significantly increased as cells differentiate into monocytes and granulocytes 9 . Subsequently CD11b gene expression is downregulated in cells proceeding towards later stages of monocytic differentiation 9 . The drop in expression of CD11b can be reproduced in vitro in human peripheral blood monocytes as they differentiate into macrophages [10] [11] [12] [13] . Although some of the elements and factors underlying the induction of the CD11b gene are known, those contributing to its down-regulation thereafter remain to be defined.
Transcriptional regulation of CD11b is an important determinant in expression of the receptor 14 . The proximal promoter of CD11b spanning nucleotides -242 to +71 appears responsible for the tissue-specific and lineage-specific expression of the gene in vitro. The CD11b promoter contains near its transcription start site elements for the transcription factors Sp1, Sp3, and PU.1 which have been shown to prime the CD11b gene for expression [15] [16] [17] .
Inducible expression of CD11b during monocytic lineage differentiation appears to be mediated by an as yet uncloned nuclear factor, named MS-2 18 . No information is available on the nature of factors that mediate transcriptional repression of the CD11b gene. We have utilized yeast onehybrid screens to identify a Krüpple-like zinc finger transcription factor, ZBP-89, which binds to the CD11b promoter and acts as a transcriptional repressor of this gene as normal monocytes differentiate into macrophages in vitro. The significance of these findings is discussed.
For personal use only. on . by guest www.bloodjournal.org From supplemented with 10% heat-inactivated FCS specified for insect cells (Sigma). Late stage monocytic differentiation into macrophage was carried out using a technique that relies on mitogenically-activated T cell contact with monocytes, thus mimicking the in vivo conversion of monocytes to macrophages by antigen-activated T cells. Briefly, normal human monocytes were isolated from leukopacks of healthy donors by Ficoll-Hypaque gradient centrifugation 10, 21 , followed by adherence to petri dishes in Iscove's medium plus10% human AB serum (Sigma, St.
MATERIALS AND METHODS

Cells
Louis, MO) for 90 min at 37 o C and in 5% CO 2 . Adherent cells were stimulated with Con A (10 GGGTCCTTAATCTGGGGCTTAATGGTGGGCCCTCTTT 3') plasmids (Fig.1 B) were also transformed into yeast after digestion with XhoI to create a background and a mutant reporter strains, respectively. Plasmid integration into the yeast genome was analyzed by plating on synthetic dropout medium lacking histidine (SD-H) but supplemented with various concentrations of 3-aminotriazole of (3-AT). The resulting reporter strains showed growth inhibition at 45 mM 3-AT. We screened a total of 9.1 millions independent colonies from a
human HeLa matchmaker cDNA library (Clontech, Palo Alto, CA). Plasmid DNAs were recovered from those colonies which were able to grow in the presence of 45 mM 3-AT and SD-HL (synthetic dropout medium without histidine and leucine). The plasmid DNAs were then transformed into the wild-type-, mutant-and background yeast strains to confirm the specificity of the interaction between the plasmid encoded protein and the bait DNA.
Plasmid Construction. A reporter plasmid, pALbWt, was used, which contains the CD11b promoter spanning nucleotides -242 to +71 fused to the luciferase gene 18 . In order to introduce the transversion mutation (G to T) at nucleotide -117 within the CD11b promoter, a two-step PCR ligation was carried out; The first PCR reaction was performed with primer 1 (5' CTAGAGTCGACCTCGAGCCAAGC 3') and primer 2 (5' CCACAGCCTGCCCAACCTTCCTCCCC 3'), and the second PCR was carried out with primer 3 (5' GGGGAGGAAGGTTGGGCAGGCTGTGG 3') and primer 4 (5'
TAGAATGGCGCCGGCCT 3'). The third PCR fragment was generated with primers 1 and 4, using the first and the second PCR fragments as a template 22 . The third PCR fragment was digested with PstI and NarI and subcloned into pALbWt. After confirming the mutation by DNA sequencing, the resulting plasmid was designated pALbM4a. Plasmids pCMVSport3-ZBP-89
(which constitutively expresses human ZBP-89 in eukaryotic cell lines) and pGEX5T-ZBP-89
(which expresses ZBP-89 fused to glutathione S-transferase (GST)) were kindly provided by Dr.
J. L. Merchant 23 . The plasmid pCMVSport3-Z (which expresses p25 in eukaryotic cell lines)
was generated by subcloning a 0.62-kb PCR product digested with SmaI and XbaI into the SmaI and XbaI sites of pCMVSport3 (GIBCO BRL, Grand Island, NY). The fusion polypeptide GST-Z was generated from pGEX4T-2-Z created by insertion of a PCR product encoding p25 digested with SmaI and XhoI into the SmaI and XhoI sites of pGEX4T-2 (Pharmacia Biotech, Piscataway, NJ). The plasmid CD11blucI-pCMV/Zeo was generated by subcloning a 1247bp fragment of pCMV/Zeo (Invitrogen, Clarsbad, CA) digested with PstI and XhoI into the SalI and PstI sites of pALbWt. The expression plasmid pPacSp1 and the parental plasmid pPacO were kindly provided by Dr. Robert Tjian 24 . Both pPacZBP-89 and pPacZ, which express human ZBP-89 and p25, respectively, were constructed by insertion of BamHI -XhoI fragments of PCR products into the BamHI and XhoI sites of pPacO. The PCR-generated fragments in each plasmid construct were confirmed by DNA sequencing.
Nuclear Extract and Total Protein Lysate Preparation. Nuclear extracts were prepared using a method modified from that described by Dignam et al 25 . Briefly, cultured cells (1.2 x 10 7 )
were harvested and washed twice with cold PBS. Cell pellets were resuspended with 2 ml of sU937-11b-luc were transfected with 25 µg of either pCMVSport3 or pCMVSport3-ZBP-89 with 1 µg of the plasmid pRSV-using electroporation, then treated with PMA at 100 ng/ml for 16 h before harvesting. After normalization of luciferase activity by -galactosidase activity, the level of luciferase in the presence of pCMVSport3 was assigned a value of 100, and the effect of ZBP-89 on luciferase activity was expressed as a percentage of this value.
For transfection of the Drosophila cell line SL2, cells were plated at a density of 3 x 10 6 /60-mm dish for 18 hrs and washed with PBS twice before transfection. A total of 2.6 µg of DNA and 10 µl of Superfect (Qiagen, Valencia, CA) were mixed in 150 µl of incomplete Schneider's Drosophila medium. After 10 min at room temperature, 0.6 ml of medium supplemented with 10% heat-inactivated fetal calf serum (tested for use with insect cells, Sigma) was added to the DNA-Superfect complexes. The suspension was then added drop-wise to the culture dishes. After a 3-h incubation at room temperature, cells were washed with PBS twice For personal use only. on November 12, 2017. by guest www.bloodjournal.org From and 2 ml of complete medium added. Cells were harvested 24 hrs later, washed two times with PBS and lysed in 150 µl of Reporter Lysis Buffer (Promega, Madison, WI). Generally, 10 µl of cell lysate were used in the -galactosidase assay (Promega, Madison, WI) and 50 µl of lysate were assayed for luciferase activity. pIE3LacZ, which expresses -galactosidase, was used in all transfections to correct for trasnfection efficiency.
Real-Time Reverse Transcription-PCR (RT-PCR).
Total RNA from U937 cells (1.0 x 10 7 ) which were treated with PMA (100 ng/ml) for 0 hr, 24 hr, 48 hr and 72hr were isolated using the TRIzol reagent (GIBCO BRL, Grand Island, NY) followed by DNase I treatment (Ambion Inc., Austin, TX) as described by the manufacturer. First strand cDNA was prepared by extension of an oligo-d(T) 16 primer with M-murine leukemia virus reverse transcriptase (Clontech, Palo Alto, CA). After incubation at 42 o C for 1 hr, the reaction was stopped by heating to 95 o C for 5 min.
Equal amounts of cDNA were subjected to PCR to detect CD11b, ZBP-89, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcripts 28 . PCR primers and TaqMan probes for ZBP-89 binds to the GC-rich element of the CD11b promoter. To confirm that p25 actually binds to the bait sequence, EMSA analyses were carried out with a radiolabeled probe (GC, the double-stranded GC-rich element used for the yeast one-hybrid screen) and GST-Z which represents the protein p25 fused to GST. The fusion proteins were expressed in soluble form in E.coli BL21 (DE3) and used for EMSA. As shown in Fig. 2A , the GST protein alone does not bind to GC (lane 2) whereas GST-Z formed a complex with GC (lane 3 . We also performed EMSA with the fusion protein GST-ZBP-89, which represents the full-length ZBP-89 protein fused to GST and obtained similar results (Fig. 2B ).
This suggests that ZBP-89 binds to the double-stranded GC-rich element of the CD11b promoter.
To investigate the binding characteristics of ZBP-89 on the CD11b promoter during myeloid differentiation, EMSA was carried out by incubating labeled GC with nuclear extracts prepared from untreated U937 cells or U937 cells treated with PMA for 24 hrs to induce their differentiation into monocyte-like cells. Fig. 2C shows that a DNA-protein complex was formed Identification of the residues in the CD11b promoter that are critical for ZBP-89 binding.
To identify the minimal region required for p25 binding, competitive gel shift assays were performed using the oligonucleotide GC1, which is 9 nucleotides shorter than GC (Fig. 3A) . As shown in Fig. 3B , a GST-Z containing complex was formed with radiolabeled GC1 and this was competed efficiently with its unlabeled equivalent (lane 3). Next, a series of oligonucleotides (M1-M6) representing sequential mutation of three or five nucleotides in GC1 were used as competing oligonucleotides. The oligonucleotides M2 -M4 lost their ability to compete for binding to GST-Z (lanes 5-7) while oligonucleotides M1, M5, and M6 effectively competed (lanes 4, 8, and 9 respectively). We also performed the same competition experiment with the fusion protein GST-ZBP-89 and obtained similar results (Fig. 3C ). These results demonstrate that p25 and ZBP-89 bind to the double-stranded oligonucleotide spanning nucleotides -127 to -113 of the CD11b promoter, thus delineating the DNA binding segment for ZBP-89.
MS-2, a putative transcription factor, binds to the GC-rich element of the CD11b promoter and might be involved in induction of the CD11b gene during myeloid cell 18 . In Fig. 3E (lane 2), we show that MS-2 is a purine-rich single-stranded DNA binding factor. Since the binding sites for p25/ZBP-89 and MS-2 overlap, it was necessary to identify a mutation which disrupts ZBP-89 but not MS-2 binding in order to assess the specific function of ZBP-89. A competitive gel shift assay was performed using GC1 as a probe, and a series of mutant double-stranded oligonucleotides (M4a-e), were used as competitors, each of which represented a different point mutation within GC1 (Fig. 3A) . Figure 3D shows that the M4a mutation which has a transversion of G to T at nucleotide -117 does not compete with the radiolabeled wild-type double-stranded probe GC1 (lane 4), indicating that G at -117 is crucial for ZBP-89 binding. The purine-rich sense strand of GC1 (GC1/for) formed an MS-2 complex (Fig. 3E, lane 2) . This complex was competed equally well with unlabelled single-stranded wildtype (GC1/for) and mutant (M4a/for) oligonucleotides (lanes 3 and 4, respectively), indicating that G at -117 is not essential for MS-2 binding. Therefore, the M4a mutation abolishes ZBP-89 (Fig. 4C) . Expression of the mutant CD11b-M4a reporter in differentiating U937 increased to 160% of the wild-type reporter (Fig. 4C) , reflecting loss of repression by endogenous ZBP-89. Thus the level of CD11b gene expression in differentiating U937 cells reflects the activity of endogenous ZBP-89.
Reconstitution of ZBP-89 repression in a heterologous expression system. Expression of
CD11b is normally restricted to differentiating myeloid cells. The CD11b-negative Drosophila Schneider L2 cell line is deficient in Sp1-related proteins 24, 30, 31 , but can express a CD11b
promoter-directed reporter when supplemented with Sp1 32 . We found this cell line to be also lacking ZBP-89 by western blotting as well as by EMSA (data not shown). We cotransfected Schneider L2 cells with 0.2 µg of the construct pPacSp1 (which expresses Sp1), together with increasing amounts of pPacZBP-89 expressing ZBP-89, along with either CD11b-wt or CD11b-M4a-luciferase plasmids. In the presence of Sp1, ZBP-89 repressed wild-type CD11b promoter activity by up to 50% (Fig. 4D) . In contrast, CD11b-M4a promoter activity was not affected by expression of ZBP-89 (Fig. 4E) . Expression of ZBP-89 alone without Sp1 did not activate the CD11b promoter (data not shown). Therefore, repression of CD11b by ZBP-89 can also be achieved in a non myeloid cellular context, and independently of the confounding effects of treatment with phorbol esters.
Expression of CD11b does not correlate with endogenous ZBP89 protein during phorbol ester-induced differentiation of U937
We next determined the correlation between the endogenous levels of CD11b mRNA and ZBP-89 protein in U937 cells differentiated by treatment with PMA for 72 hrs, a treatment which alters homotypic adhesion in these cells (Fig. 5A ). Both ZBP-89 protein and CD11b mRNA increased in parallel during the differentiation of PMA-treated U937 into monocyte-like cells (Fig.5B) . Thus whereas over-expressed ZBP-89 represses the CD11b gene, we find no inverse correlation between endogenous ZBP-89 and expression of the CD11b gene in this system. compare left and right panels) as described 21, 33 . As shown in Fig. 6B , CD11b mRNA dropped significantly (by ~75%) in macrophages compared to monocytes. Importanly, this reduction coincided with an increase of protein expression of ZBP-89 (Fig. 6C, compare lanes 3, 4) that has an identical mobility to the form induced in differentiating U937 cells (Fig. 6C, lanes 1-2; compare lanes 2 and 4). These data suggest that ZBP-89 exerts its repressor activity on CD11b during the late stages of monocytic differentiation.
DISCUSSION
The major finding in this paper is that ZBP-89 is a repressor of the CD11b gene.
Repression is dose-dependent, sequence-specific, and is demonstrable in non-myeloid insect cells. In the U937 model of early stage monocytic differentiation, no inverse correlation was observed between ZBP-89 levels and CD1b gene expression. However, in the model of late stage monocyte to macrophage differentiation, such as inverse correlation was readily detected.
Consequently, these findings suggest that the effect of ZBP-89 on CD11b gene expression occurs primarily at the later rather than the early stages of monocytic differentiation. This observation may underlie the observed drop in the levels of CD11b as monocytes differentiate into tissue macrophages in vivo. Second, the repressor may block interaction of an activator with other components of the transcription machinery 48 ; third, it can displace an activator from its DNA element by competition 49 , and fourth, the DNA element itself may exert allosteric effects on transcriptional regulators, such that regulators may activate transcription in the context of one gene, yet repress transcription in another 50, 51 . In regulating expression of the enolase and gastrin genes, ZBP-89
For personal use only. on November 12, 2017. by guest www.bloodjournal.org From acts as a bona-fide transcriptional repressor; it inhibits basal as well as activated transcription, an effect not mediated by squelching 26, 34 . Recent data have shown that ZBP-89, can compete with Sp1 in regulating expression of the vimentin gene 39 . Sp1 is also required in CD11b transcriptional activation 32 , suggesting that some of the repressor activity may be mediated through this mechanism. ZBP-89 and Sp1 do not, however, cross compete in EMSA analyses (lanes 9, 10 in Fig. 2C ), suggesting that interaction may take place at the protein-protein level. It is possible that the promoter context and cell type could also contribute to ZBP-89 repressor activity. In this situation, ZBP-89 might act through interaction with an adjacent transcriptional activator, modulating its functional state or local concentration.
The ZBP-89 element overlaps with but is distinct from that of MS-2, a single-stranded DNA binding factor of the CD11b gene whose identity remains to be determined 18 (Fig. 3 ).
ZBP-89 may repress by competing with MS-2 for DNA binding 48 . Supporting this notion is our observation that the activity of the mutant promoter CD11b-M4a is higher than that of CD11b-wt (Fig. 4B ). This increase may also be due to the blocked binding of endogenous ZBP-89. In the proximal promoter of the NMDAR1 gene, a GC-rich element contains the binding sites for the double-stranded DNA binding proteins, Egr-1 and Sp1, and both sense and antisense strands of this element also form complexes with yet to be identified factors 56 . Considering that the DNA macromolecule is a dynamic structure capable of assuming a single-stranded conformation under certain conditions, changes in the secondary structure of the CD11b promoter may be critical in controlling CD11b gene expression. 
